Overview

Abraxane is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer after other treatments have failed. Abraxane may be also referred to by its drug name…

Overview
Ado-trastuzumab emtansine is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat some cases of HER2-positive, metastatic breast cancer. Ado-trastuzumab emtansine may be…

Afinitor (everolimus) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat postmenopausal women with advanced hormone receptor-positive (HR-positive), human epidermal growth factor receptor 2-negative (HER2-negative) breast cancer.

Overview
Arimidex is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat breast cancer in postmenopausal women in cases where the cancer is early-stage and hormone receptor-positive…

Overview
Aromasin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) in 2005 to treat estrogen receptor-positive breast cancer after menopause. Aromasin is used as an adjuvant, or…

Overview

Beizray is approved by the U.S. Food and Drug Administration (FDA) for the treatment of breast cancer. It is indicated as a single agent for locally advanced or metastatic breast cancer after failure of previous…

Datroway (datopotamab deruxtecan-dlnk) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Overview
Ellence is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat people with axillary node tumor involvement after removal of primary breast cancer. Ellence may be also referred to…

Enhertu (fam-trastuzumab deruxtecan-nxki) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with certain HER2-positive, HER2-low, or HER2-ultralow breast cancers.

The Fareston brand name has been discontinued in the U.S. Other brand name or generic alternatives may be available.

Overview

Fareston is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to…

Faslodex (fulvestrant) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat certain adults with hormone receptor-positive breast cancer.

Overview
Femara is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat estrogen receptor-positive breast cancer in postmenopausal women. Femara is used as an adjuvant, or post-surgical…

Overview
Gemzar is approved by the U.S. Food and Drug Administration (FDA) for use in combination with the chemotherapy drug paclitaxel as a first-line treatment for metastatic breast cancer in individuals who have not…

Overview
Halaven is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in adults who have previously received two chemotherapy regimens. Halaven may be also…

Herceptin (trastuzumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with HER2-overexpressing breast cancer.

Herceptin Hylecta (trastuzumab/hyaluronidase-oysk) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with HER2-overexpressing breast cancer.

Hercessi (trastuzumab-strf) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with HER2-overexpressing breast cancer.

Herzuma (trastuzumab-pkrb) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with HER2-overexpressing breast cancer.

Ibrance (palbociclib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat certain adults with breast cancer.

Overview
Infugem is approved by the U.S. Food and Drug Administration (FDA) for use in combination with paclitaxel as a first-line treatment for metastatic breast cancer. It is specifically used when previous…

Inluriyo (imlunestrant) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat some adults with certain types of metastatic breast cancer.

Itovebi (inavolisib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat some adults with certain types of breast cancer.

Overview
Ixempra is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic or locally advanced breast cancer after at least two other therapies have not worked. Ixempra may be…

Kadcyla (ado-trastuzumab emtansine) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with certain HER2-positive breast cancer.

Kanjinti (trastuzumab-anns) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Keytruda (pembrolizumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat certain adults with triple-negative breast cancer.

Kisqali (ribociclib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with certain hormone receptor-positive, HER2-negative breast cancer.

Lynparza (olaparib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with certain inherited BRCA-mutated, HER2-negative breast cancer.

Margenza (margetuximab-cmkb) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with metastatic HER2-positive breast cancer.

Nerlynx (neratinib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Ogivri (trastuzumab-dkst) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Ontruzant (trastuzumab-dttb) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Orserdu (elacestrant) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat postmenopausal women and adult men with certain kinds of breast cancer.

Perjeta (pertuzumab) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with HER2-positive breast cancer.

Overview
Pertuzumab is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and chemotherapy or anti-HER2…

Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Piqray (alpelisib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) in combination with fulvestrant to treat adults with HR-positive, HER2-negative, PIK3CA-mutated advanced or metastatic breast cancer following progression on or after endocrine therapy.

Poherdy (pertuzumab-dpzb) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with HER2-positive breast cancer.

Soltamox (tamoxifen citrate) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat certain adults with breast cancer.

Talzenna (talazoparib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with deleterious or suspected deleterious germline BRCA-mutated, HER2-negative locally advanced or metastatic breast cancer.

Tamoxifen is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat certain adults with breast cancer.

Overview
Taxotere is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat locally advanced or metastatic breast cancer after chemotherapy hasn’t worked. Taxotere is also approved to treat…

Overview
Trastuzumab is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and one or more chemotherapy…

Trazimera (trastuzumab-qyyp) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Trodelvy (sacituzumab govitecan-hziy) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with certain types of breast cancer.

Truqap (capivasertib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat some adults with breast cancer.

Tukysa (tucatinib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with human epidermal growth factor receptor-2 (HER2)-positive breast cancer.

Tykerb (lapatinib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Veppanu (vepdegestrant) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults with breast cancer.

Verzenio (abemaciclib) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating adults with breast cancer.

Overview
Xeloda is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer. Xeloda may be prescribed either as monotherapy (on its own) in cases resistant to…

Overview
Zoladex is approved by the U.S. Food and Drug Administration (FDA) for the palliative treatment of advanced breast cancer in premenopausal and perimenopausal women, according to the prescribing information. This…